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Introduction
Missing outcome data are a common threat to the validity of randomized trials and, subsequently, their meta-analysis. Because missing data are by definition not present in the dataset, addressing them requires making untestable assumptions. Researchers undertaking meta-analyses typically ignore missing data and analyze complete data only; we refer to such an analysis as an available cases analysis (ACA).
Assumptions about missing data were classified by Little and Rubin (2002) . In the randomized trial setting, data are missing completely at random if the probability of a missing outcome is unrelated to any baseline variables, randomized group, or outcome. Data are missing at random (MAR) if the probability of a missing outcome is unrelated to the outcome, conditional on baseline variables and a randomized group. With no baseline variables, MAR means that missing outcomes do not differ systematically from observed outcomes in the same randomized group. An ACA therefore assumes MAR. Data are missing not at random (MNAR) if they are not MAR: that is, if the probability of a missing outcome is related to the outcome, conditional on baseline variables and a randomized group. If data are MNAR, then an ACA is likely to be biased.
Here we consider randomized trials with an outcome measured at a single time point, for which outcome data are unavailable for some of the participants within the trial. Furthermore, we focus on approaches that are based on aggregate (summary) data from the trial, such as are often available from journal articles, and that are typical of the data available for a meta-analysis.
The use of pattern mixture models has been previously suggested for handling missing outcome data in meta-analysis of binary outcomes with aggregate data . This approach is based on the informative missingness odds ratio (IMOR), which relates the odds of outcome in the missing data to that in the observed data. The approach can allow for uncertainty in the IMOR and has been implemented in Stata in the metamiss command.
Parameters like the IMOR that measure departure from a MAR assumption have been called sensitivity parameters by Kenward, Goetghebeur, and Molenberghs (2001) ; we follow White, Kalaitzaki, and Thompson (2011) in calling them informative missingness parameters (IMPs). Mavridis et al. (2015) extended the IMP framework to meta-analyses with continuous outcomes by defining IMPs that relate the mean of the outcome between the missing and the observed participants.
Network meta-analysis (NMA) combines the results of multiple direct comparisons (Salanti et al. 2008) and is therefore prone to the same biases as pairwise meta-analysis. More specifically, incorrectly handling missing data in one or more comparisons of a NMA could affect all relative effects in which this particular comparison is involved either directly or indirectly (Salanti et al. 2014) . Methods used to allow for IMPs in pairwise meta-analysis apply directly to NMA when only two-group trials are included. In the presence of multigroup trials, the "adjusted" covariance between relative effects from the same study also needs to be estimated (Mavridis et al. 2015) . The application of IMPs in NMA with binary outcome data has been exemplified in a Bayesian framework by Spineli et al. (2013) .
The aim of this article is to introduce a new Stata command, metamiss2, with new syntax, which extends metamiss by handling continuous and binary outcome data and by working in NMA and pairwise meta-analysis. metamiss2 performs a two-stage analysis: stage 1 estimates the "adjusted" study-specific relative effects and their variances and covariances, and stage 2 calls metan (Harris et al. 2008) or metaan (Kontopantelis and Reeves 2010) (for pairwise meta-analysis) and network meta (White 2015) (for NMA) to obtain the summary effects.
Theory
This section describes stage 1 of the analysis, which estimates the treatment effects and their variances for each study allowing for MNAR data. The second stage combines the first-stage estimates using a standard meta-analysis procedure (Palmer and Sterne 2016) and is not further described here. We describe first the case of binary data and then of continuous data. Our notation follows that of Mavridis et al. (2015) but is extended to cover the case of binary data as in .
Binary outcome data
We assume we have data from multiple studies, each with two groups denoted T (treatment) and C (control). We assume that in the jth group of the ith study (j = C, T ), we know n ij , the number of participants providing outcome data, and m ij , the number of participants with missing outcome data. We also assume we know r ij , the number of observed successes.
The model for the observed data is r ij ∼ Bin(n ij , χ obs ij ). Then, χ obs ij is the "true" mean of the observed outcomes in the jth group of the ith study.
Our measure of interest in the ith study is defined as
where χ tot ij is the true mean outcome of all (observed and missing) outcomes in the jth group of the ith study. The link function f (·) may be the identity function f (x) = x (so that the measure of interest is the risk difference), the logarithmic function f (x) = log(x) (giving the log risk-ratio), or the logit function f (x) = logit(x) (giving the log oddsratio).
In this simple setting, a MAR assumption would imply that χ tot ij = χ obs ij (Little and Rubin 2002) . Under MNAR, we view the mean outcome of all participants as a mixture of outcomes in the observed and in the missing participants. We write
where π ij ∼ Beta(n ij , m ij ) is the probability of a participant being observed in the data and χ miss ij is the (unobserved) mean outcome in the missing data. We introduce the IMP as
We consider the case where g is the logit function g(x) = logit(x) and the IMP is the log of IMOR . When λ ij = 0, we assume that the outcome in the missing participants is on average the same as the outcome in the observed participants. This is equivalent to assuming MAR. We quantify departures from the MAR assumption by allowing λ ij to assume nonzero values.
Continuous outcome data
If the outcome is continuous, we assume we again know n ij , m ij . We also know x obs ij , the mean of the observed outcomes, and s ij , the standard deviation (SD) of the observed outcomes.
The model for the observed data is x (1), where f may be the identity function f (x) = x (giving the mean difference) or the logarithmic function f (x) = log(x) (giving the log ratio of means); alternatively, f (x) may be replaced by f i (x) = x/σ i , where σ i is the pooled SD in the ith study, giving the standardized mean difference (White and Thomas 2005) .
The IMP (λ ij ) is then expressed using (2) and (3). For a continuous outcome, g may be the identity function g(x) = x (so the IMP is the informative missingness difference of means or IMDOM) or the logarithmic function g(x) = log(x) (so the IMP is the log of the informative missingness ratio of means or logIMROM) (Mavridis et al. 2015) . We generally expect researchers to use IMDOM with mean difference and standardized mean difference and IMROM with ratio of means.
Estimation
The IMPs λ ij are required to estimate β i but are not identified by the observed data. Instead, they are specified by the analyst on the basis of subject-matter knowledge or a range of values is assumed in a sensitivity analysis. By allowing for uncertainty in the IMPs, the model reduces the relative weight given to studies with more missing data . The IMPs may be specified as independent across groups, λ ij ∼ N (µ λij , σ 2 λij ), or we can allow for correlation by assuming a bivariate normal distribution with corr(λ iT , λ iC ) = ρ λi . Thus, nonzero values of any of µ λiT , µ λiC , σ 2 λiT , and σ 2 λiC imply MNAR. The IMPs are assumed to be independent across studies to abide by the fundamental assumption of independent studies in meta-analysis. Two estimation procedures are described briefly here and in more detail in Mavridis et al. (2015) . We write β i = β i (θ i ), where θ i = (π iT , π iC , χ obs iT , χ obs iC , λ iT , λ iC ). In the Taylor method, which uses a linear approximation to β i (θ i ), the point estimate of β i is β i = β i ( θ i ), where θ i = ( π iT , π iC , χ obs iT , χ obs iC , λ iT , λ iC ), and its estimated variance is
is a block diagonal matrix combining the sampling variance for π iT , π iC , χ obs iT , and χ obs iC and the uncertainty variance for µ λiT and µ λiC . In the parametric bootstrap method, which avoids the linear approximation to β i (θ i ), values θ * i are repeatedly drawn-π iT , π iC , χ obs iT , and χ obs iC independently from their posterior distributions given the data, and λ iT and λ iC jointly from their prior distribution-and the point estimate β and its estimated variance are the mean and variance of the β i (θ * i ). When the measure of interest is the standardized mean difference, the procedure takes σ i as the pooled SD across groups and ignores uncertainty in σ i .
The same methods are used for multigroup studies, which may arise in NMA. Multigroup studies yield multiple treatment effects, for example,
Extending the estimation method above yields estimates of their variances and the covariance cov( β i1 , β i2 ) (Mavridis et al. 2015) .
3 The metamiss2 command
compare(string) sensitivity smd md rom sdpool(on | off) rr or rd taylor bootstrap reps(integer ) seed(integer ) fixed tau2(string) inconsistency nometa metanoptions(meta options) networkoptions(network meta options)
nokeep varchange netplot trtlabels(string) netplotreference(string) netplotoptions(intervalplot options)
where varlist is
• for pairwise meta-analysis with continuous outcome data: nE mE yE sdE nC mC yC sdC-variables containing the numbers of observed and missing participants and the mean and SD of the observed data in experimental and control groups, respectively.
• for pairwise meta-analysis with binary outcome data: rE fE mE rC fC mC-variables containing the numbers of successes and failures in the observed data and the number of missing participants in experimental and control groups, respectively.
• for NMA: varlist is not used, but the data must have been prepared using the network setup command (White 2015) in the "augmented" format (see example 4.3).
Options
Options for specifying the IMPs imptype(imdom | logimrom) specifies the type of IMP for continuous outcome data. imdom indicates the informative missingness difference of means, and logimrom indicates the log of the informative missingness ratio of means. The default is imptype(imdom). This option is not needed for binary outcome data because the only available IMP is logIMOR. For details on IMDOM, logIMROM, and logIMOR, see section 2, Mavridis et al. (2015) , and .
impmean(# # . . . #) specifies the mean of the assumed (normal) distribution for IMP.
The default value is 0 in all groups. If one value is given, it is the mean for all groups. For pairwise meta-analysis, if two values are given, they are the means for the experimental and control group. For NMA, if T values are given (with T the total number of treatments), they are the means for the reference treatment and the nonreference treatments in the order shown in network setup (White 2015) . Each # may be a single value corresponding to all studies or a variable containing study-specific values.
impsd(# # . . . #) specifies the SD of the assumed (normal) distribution for IMP in the same way as described above for impmean(). The default value is impsd(0) in all groups.
impcorrelation(real | exp | matrix ) specifies the correlation of the IMP between the different groups. The default value is impcorrelation(0). A common correlation value for all pairs of treatments or the full correlation matrix (only for NMA) can be specified.
compare(string) specifies a second assumption for IMP to be compared with the primary analysis. string may include impmean(), impsd(), and impcorrelation().
sensitivity specifies a sensitivity analysis for the IMP assuming a range of different standard deviations for its distribution with impmean(0) or a different specified impmean().
Options for continuous data smd specifies the standardized mean difference as the measure of interest (the default for continuous data).
md specifies the mean difference as the measure of interest.
rom specifies the ratio of means as the measure of interest.
sdpool(on | off) specifies whether the SD is pooled across groups in computing variances. Following metan, the default option for mean difference and ratio of means is sdpool(off); for standardized mean difference, the default option is sdpool(on).
Options for binary data rr specifies the risk ratio (RR) as the measure of interest (the default for binary data). Note that in this case, the IMP is the logIMOR.
or specifies the odds ratio as the measure of interest. Note that in this case, the IMP is the logIMOR.
rd specifies the risk difference as the measure of interest. Note that in this case, the IMP is logIMOR.
Estimation options
taylor specifies that Taylor-series approximation be used to integrate over the distribution of the IMP (the default).
bootstrap specifies that parametric bootstrap be used to integrate over the distribution of the IMP.
reps(integer ) specifies the number of simulations under the bootstrap method. The default is reps(10000).
seed(integer ) specifies the initial value of the random-number seed for the bootstrap method. The default is seed(0). See [R] set seed for more details.
Meta-analysis options
fixed specifies the use of the fixed-effect model instead of the default random-effects model.
tau2(string) specifies the use of an estimator for the heterogeneity variance. This option is available only for pairwise meta-analysis, and valid estimators are the available estimators in metaan (Kontopantelis and Reeves 2010) . The default is the DerSimonian and Laird estimator using metan (Harris et al. 2008) .
inconsistency specifies the use of an inconsistency model for the case of NMA instead of the consistency model, which is the default.
nometa skips the conduct of pairwise or network meta-analysis after estimating the "adjusted" study-specific effect sizes and variances.
metanoptions(meta options) specifies any valid options of metan (Harris et al. 2008) .
networkoptions(network meta options) specifies any valid options of network meta (White 2015) .
Output options
nokeep specifies that study-specific "adjusted" effect sizes and standard errors and variances be dropped from the dataset. By default, these estimates are stored as extra variables for pairwise meta-analysis with names ES, seES (as in metan) and in NMA with prefix imp .
varchange specifies that the "adjusted" study-specific relative effects and variances be stored in the dataset, replacing the respective values obtained from the network setup command. This means that the current assumptions about the missing data will also apply to future analyses of the data.
netplot specifies that a forest plot with the relative effects from NMA be drawn. The same forest plot can be produced by running the intervalplot command (Chaimani and Salanti 2015) after metamiss2 for a network meta-analysis. Note that for the case of pairwise meta-analysis, a forest plot is produced by default.
trtlabels(string) specifies the labels of the treatments for the case of NMA. These labels, separated with spaces, will be used in the forest plot. The first label should correspond to the reference treatment, and the other treatment should be given in the numerical or alphabetical order of their codes in the data.
netplotreference(string) specifies a treatment to be used as a reference in the forest plot so that only a subset of the relative effects from the NMA (that is, every treatment versus that reference) will be given in the forest plot. The treatment specified here can be different from the reference treatment of the analysis.
netplotoptions(intervalplot options) specifies any valid options of intervalplot (Chaimani and Salanti 2015) .
Examples 4.1 Pairwise meta-analysis, binary data
We illustrate the use of metamiss2 for meta-analysis with binary aggregate outcome data using a dataset that includes 17 trials comparing the effectiveness of haloperidol with placebo for the treatment of schizophrenia. The outcome is clinical response, and RR > 1 suggests that haloperidol works better that placebo. We explore different assumptions about the association of the outcome between missing and observed data, which we describe by the logIMOR.
First, we assume that our beliefs about the missing data can be expressed as follows. In the haloperidol group, we believe there may be systematic differences between outcomes in missing and observed participants, but we are not sure in which direction, so we give the logIMOR a distribution with mean 0 and SD 1. In the placebo group, we believe the response in missing participants is probably worse than in observed participants, so we give the logIMOR a distribution with mean −1 and SD 1. This can be the case, for example, when patients drop out of the study because their symptoms have worsened. We use the default method of estimation, which is Taylor-series approximation. We use the metan option lcols(author) to label the studies.
. metamiss2 rh fh mh rp fp mp, impmean(0 -1) impsd(1) metanopt(lcols(author)) ******************************************************************* ******** METAMISS2: meta-analysis allowing for missing data ******* ******** Informative missingness parameter with uncertainty ******* ******************************************************************* 
Heterogeneity chi-squared = 20.66 (d.f. = 16) p = 0.192 I-squared (variation in ES attributable to heterogeneity) = 22.6% Estimate of between-study variance Tau-squared = 0.0863 Test of ES=1 : z= 4.87 p = 0.000
After we run metamiss2, the "adjusted" study-specific relative effects along with their 95% confidence intervals are given in the output. The same results are obtained when we run the same analysis with metamiss:
. metamiss rh fh mh rp fp mp, logimor(0 -1) sdlogimor(1) method(Taylor) > randomi lcols(author) ******************************************************************* ******** METAMISS: meta-analysis allowing for missing data ******** ******** Bayesian analysis using priors ******** ******************************************************************* Measure: RR. Zero cells detected: adding 1/2 to 6 studies. Priors used: Group 1: N(0,1^2). Group 2: N(-1,1^2). Correlation: 0. Method: Taylor series approximation.
(Calling metan with options: randomi lcols(author) eform ...) 
---------------------+---------------------------------------------------D+L pooled ES
| 2.211 1.607 3.042 100.
---------------------+---------------------------------------------------
Heterogeneity chi-squared = 20.66 (d.f. = 16) p = 0.192 I-squared (variation in ES attributable to heterogeneity) = 22.6% Estimate of between-study variance Tau-squared = 0.0863
Test of ES=1 : z= 4.87 p = 0.000
The above analysis implicitly assumes that the IMPs in the two groups are unrelated. We next assume that a high logIMOR in one group is likely to go with a high logIMOR in the other group; that entails the two logIMORs are positively correlated, with correlation ρ = 0.5. We obtain the study-specific RRs using the bootstrap method:
. metamiss2 rh fh mh rp fp mp, impmean(0 -1) impsd(1) impc(0.5) bootstrap > metanopt(lcols(author)) ******************************************************************* ******** METAMISS2: meta-analysis allowing for missing data ******* ******** Informative missingness parameter with uncertainty ******* ****************************************************************** 
--------------------+---------------------------------------------------

.71 ---------------------+---------------------------------------------------D+L pooled ES
| 2.329 1.603 3.384 100. Running the same analysis with metamiss gives slightly different results:
---------------------+---------------------------------------------------
. metamiss rh fh mh rp fp mp, logimor(0 -1) sdlogimor(1) corrlogimor(0.5) method(mc)randomi lcols(author) reps(10000) ******************************************************************* ******** METAMISS: meta-analysis allowing for missing data ******** ******** Bayesian analysis using priors ******** ******************************************************************* Measure: logRR. Zero cells detected: adding 1/2 to 6 studies. Priors used: Group 1: N(0,1^2). 
---------------------+---------------------------------------------------D+L pooled ES
| 2.141 1.613 2.843 100. This difference in results is due to a) random error of the simulations and b) the different way the two commands handle studies without missing participants in one or both groups. More specifically, for these trials, metamiss2 assumes that the probability of observing the data is π ij = 1, while metamiss assumes that the probability is not constant but a random variable.
---------------------+---------------------------------------------------
An important advantage of metamiss2 when using the bootstrap method is that it runs much faster (that is, about 10 times) than metamiss because of coding in Mata.
Pairwise meta-analysis, continuous data
The second example involves data from eight trials that compare the effectiveness of mirtazapine versus placebo for major depression. The outcome is change in depression symptoms measured on a standardized rating scale [ We first describe the departure from MAR using the IMDOM. We assume a systematic departure from the MAR assumption where for the mirtazapine group, IMDOM has mean −0.5 with SD(IMDOM) = 1 and where for the placebo group, IMDOM has mean 1 with SD(IMDOM) = 1.5. This means that we think it is likely that missing participants had better outcomes than observed participants in the mirtazapine group (for example, they left the study because of early response with important side effects), while the opposite is true in the placebo group (for example, they left the study because of lack of efficacy). We also assume that IMDOMs are correlated between the two groups with ρ = 0.5, and we compare the results with ACA (that is, when IMP = 0 without uncertainty):
. metamiss2 nm mm ym sdm np mp yp sdp, impmean(-0.5 1) impsd(1 1.5) impcorr(0.5) > compare(impmean(0) impsd(0)) md metanopt(lcols(study)) Primary analysis ******************************************************************* ******** METAMISS2: meta-analysis allowing for missing data ******* ******** Informative missingness parameter with uncertainty ******* ******************************************************************* Informative missingness parameter: IMDOM Measure of interest:
Mean difference Assumed distribution for IMP:
Experimental group~N(-.5,1^2) Control group~N(1,1.5^2) IMP correlation between groups:
.5 Method for first stage model:
Taylor series approximation Second stage model:
Random effects meta-analysis (Calling metan with options: lcols(study) ...) Secondary analysis ******************************************************************* ******** METAMISS2: meta-analysis allowing for missing data ******* ******** Available cases analysis ******** ******************************************************************* Informative missingness parameter: IMDOM Measure of interest:
Mean difference Method for first stage model:
Random effects meta-analysis (Calling metan with options: lcols(study) ...) ------------------------------------------------------------------------- Next, we change the IMP to the IMROM. To investigate how the summary effect and its variance changes under different levels of uncertainty assumed for the IMP, we run a sensitivity analysis with IMROM = 1 on a range of different values for SD(logIMROM) using the bootstrap method:
. metamiss2 nm mm ym sdm np mp yp sdp, md sensitivity imptype(logimrom) ******************************************************************* ******** METAMISS2: meta-analysis allowing for missing data ******* ******** Informative missingness parameter with uncertainty ******* **** Sensitivity analysis assuming departures from MAR ***** ******************************************************************* Figure 1 . Plot of the summary mean difference of mirtazapine versus placebo and the respective 95% confidence interval (random-effects meta-analysis) for various values of SD(logIMROM) under the IMROM = 1 assumption Figure 1 shows that increasing the uncertainty of the IMP results in a narrower confidence interval for the summary effect up to some point (∼ SD = 3); this is related to the reduction of heterogeneity due to the extra variance introduced in the study-specific estimates. However, when large uncertainty is assumed for IMP (SD > 3), then this uncertainty is also reflected in the summary effect; therefore, the confidence interval becomes wider.
Network meta-analysis
To illustrate the use of metamiss2 in NMA, we use a dataset that comprises a network of 12 trials comparing the effectiveness of 9 antidepressants. The outcome is again measured as the change score on the Hamilton Depression Rating Scale 21-Item (HAMD 21) depression scale. Because of the complicated structure of data, metamiss2 does not take arguments for the outcome when applied to NMA. Instead, the command metamiss2 will be executed after the data have been set up with the network setup command (White 2015) . This applies to any type of outcome that is handled with the network setup command.
We first prepare the data in the "augmented" format using the network package (version 1.2.3 here) that calls mvmeta (version 3.1.3 here):
. network setup y sd n, trt(t) stud (id) We then run metamiss2 without arguments to obtain the ACA:
. metamiss2 ******************************************************************* **** METAMISS2: network meta-analysis allowing for missing data *** ******** Available cases analysis ******** ******************************************************************* Informative missingness parameter: IMDOM Measure of interest:
Random effects network meta-analysis (Calling network meta ...)
Command is: mvmeta _y _S , bscovariance(exch 0.5) longparm suppress(uv mm) > vars(_y_2 _y_3 _y_4 _y_5 _y_6 _y_7 _y_8 _y_9) Note: using method reml Note: using variables _y_2 _y_3 _y_4 _y_5 _y_6 _y_7 _y_8 _y_9 Note: 12 observations on 8 variables Note: variance-covariance matrix is proportional to .5*I (8) To explore the impact of alternative assumptions, we incorporate IMPs in our analysis. As in pairwise meta-analysis, IMPs can be treatment specific. There are 9 treatments in the network, and assumptions for the outcome among missing participants can be different depending on the administered treatment. Here we consider that treatments 1, 2, 6, and 8 are associated with IMDOM = 1; for treatments 3, 4, and 9, IMDOM = −1; and for treatments 5 and 7, IMDOM = 0. We assume SD(IMDOM) = 1 for all treatments in the network. Additionally, drug-specific IMDOMs can be correlated depending on the nature of missing data. Information about the pairwise correlation between the 9 IMDOMs has to be collected in a matrix. In the matrix shown below, the correlation between the IMDOMs for treatments 4 and 6 is ρ 4,6 = 0.5 and between treatments 5 and 6 is ρ 5,6 = 0.2: 
Note that here the choice of the correlation matrix is arbitrary, but in practice, it should be defined on the basis of expert opinion. The matrix can be specified using the matrix command:
. matrix C=J(9,9,0.5)+0.5*I(9) . forvalues i=4/8{ 2. matrix C[`i´,`=`i´+1´]=0.2 3. matrix C[`=`i´+1´,`i´]=0.2 4. } . matrix list C symmetric C [9, 9] c1 c2 c3 c4 c5 c6 c7 c8 c9 r1 1 r2 .5 1 r3 .5 .5 1 r4 .5 .5 .5 1 r5 .5 .5 .5 .2 1 r6 .5 .5 .5 .5 .2 1 r7 .5 .5 .5 .5 .5 .2 1 r8 .5 .5 .5 .5 .5 .5 .2 1 r9 .5 .5 .5 .5 .5 .5 . Accounting for missing outcome data in this particular example had little impact on the results, which might be due to the arbitrary assumptions we made about the IMPs. Treatment 8 appears to be more effective than treatment 1, as in the ACA. The confidence intervals of all relative effects are slightly narrower compared with ACA, while heterogeneity was estimated to be near zero.
Discussion
metamiss2 and metamiss are almost equivalent for meta-analyses with binary outcome data, and they give identical answers when the Taylor-series method is used to account for uncertainty. However, small discrepancies exist between the two commands. First, metamiss has the option to perform analyses of missing binary data based on reasons for missingness (White and Higgins 2009) . This approach allows different assumptions to be made within each study group at the patient level and not only on average as metamiss2 . Second, the option to use the GaussHermite quadrature estimation method is not available in metamiss2. However, the parametric bootstrap method in metamiss2 is very fast and thus can be used routinely as an alternative to quadrature. Note that the Monte Carlo method, which is available in metamiss, is fully Bayesian and thus can show small numerical differences from the parametric bootstrap method in metamiss2.
A limitation of metamiss2 is that finite-sample correction for standardized mean difference has not been incorporated in the present code; this correction allows for uncertainty in the observed study-specific standard deviations when trial sample sizes are small. Future work will explore the potential to enable an assumption that IMPs are correlated across different studies (White et al. 2008, 2) .
There is no unique best approach to handle missing outcome data in meta-analysis with aggregate data. ACA is usually a sensible starting point and will often be the primary analysis. Because the IMP parameters cannot be estimated from the observed data, values must be given to them based on judgment and on evidence external to the meta-analysis. Thus, sensitivity analyses using different plausible values of IMPs are necessary to assess the robustness of results to different assumptions about the missing data. The sensitivity option in metamiss2 sets the IMP means and correlation to zero and gradually increases the IMP standard deviations. This reflects a minor departure from MAR. In practice, we would expect the IMP mean to be nonzero. We may conduct additional sensitivity analyses changing the value of both mean and SD (one at a time) of IMP parameters and assuming each of them common and different across groups and monitor how sensitive results are to these changes. Other sensitivity analysis strategies were suggested by . In all cases, discussion with subject matter experts is needed to choose sensible distributions for the IMPs.
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